Our inaugural VentureX Summit in 2025 convened leading researchers, entrepreneurs, investors, clinicians, and industry executives to explore the future of biomedical innovation, with particular emphasis on breakthroughs in kidney disease therapeutics and neurodegenerative disorders such as Alzheimer’s disease. The event highlighted emerging scientific discoveries, commercialization pathways, and investment opportunities aimed at accelerating the translation of academic research into patient-impacting therapies. Through plenary sessions, fireside chats, technology showcases, and networking opportunities, participants examined successful models for advancing kidney disease treatments, fostering precision medicine, and driving innovation in neuroscience and brain health. The summit also showcased UTMB’s growing leadership in entrepreneurship and translational research, strengthening collaborations across academia, industry, and the investment community to advance next-generation healthcare solutions.